Results 251 to 260 of about 358,441 (297)
Preoperative embolization of feeding arteries in glioblastoma: Technical strategies and clinical utility. [PDF]
Acta Neurochir (Wien)Uchida M +11 more
europepmc +1 more source
Decoding the Glioblastoma Microenvironment: AI-Driven Analysis of Cellular MRI Signatures for Targeted Therapy. [PDF]
Cell Mol NeurobiolSun Y, Wang K, Ye T.
europepmc +1 more source
Highlights in IO: next-generation CAR-T therapy for glioblastoma. [PDF]
J Immunother CancerYamaguchi J, Okada H.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
2016
Glioblastoma is the most common and aggressive primary brain tumor in adults. Defining histopathologic features are necrosis and endothelial proliferation, resulting in the assignment of grade IV, the highest grade in the World Health Organization (WHO) classification of brain tumors.
Wirsching, H G, Galanis, E, Weller, M
+7 more sources
Glioblastoma is the most common and aggressive primary brain tumor in adults. Defining histopathologic features are necrosis and endothelial proliferation, resulting in the assignment of grade IV, the highest grade in the World Health Organization (WHO) classification of brain tumors.
Wirsching, H G, Galanis, E, Weller, M
+7 more sources
Intraventricular Glioblastomas
World Neurosurgery, 2016Although glioblastoma is the most common primary brain tumor, primary intraventricular locations are extremely rare; only 21 cases have been reported to date.A retrospectively acquired database of all intracranial glioblastomas treated in 2 different neurosurgical departments during the last 10 years was queried.
Atef Ben Nsir +5 more
openaire +2 more sources
Journal of Clinical Oncology, 2017
Glioblastoma (GBM) is a rare tumor and one of the most challenging malignancies to treat in all of oncology. Although advances have been made in the treatment of GBM, encouraging outcomes typically are not observed; patients diagnosed with these tumors generally have a dismal prognosis and poor quality of life as the disease progresses.
Brian M, Alexander, Timothy F, Cloughesy
openaire +2 more sources
Glioblastoma (GBM) is a rare tumor and one of the most challenging malignancies to treat in all of oncology. Although advances have been made in the treatment of GBM, encouraging outcomes typically are not observed; patients diagnosed with these tumors generally have a dismal prognosis and poor quality of life as the disease progresses.
Brian M, Alexander, Timothy F, Cloughesy
openaire +2 more sources
Pediatric Blood & Cancer, 2009
AbstractWe describe the case a 2‐day‐old female with congenital glioblastoma. Total resection was followed by adjuvant and high dose chemotherapy, as indicated by the current Italian infant protocol. The child is alive and well 18 months after diagnosis. A review of 67 selected congenital brain tumors showed the mortality rate was 82%.
G.M. Milano +6 more
openaire +2 more sources
AbstractWe describe the case a 2‐day‐old female with congenital glioblastoma. Total resection was followed by adjuvant and high dose chemotherapy, as indicated by the current Italian infant protocol. The child is alive and well 18 months after diagnosis. A review of 67 selected congenital brain tumors showed the mortality rate was 82%.
G.M. Milano +6 more
openaire +2 more sources
Current Treatment Options in Neurology, 2009
Optimal management of newly diagnosed glioblastoma multiforme includes maximal surgical resection, followed by 60 Gy of external beam radiation plus concomitant daily temozolomide and at least six additional monthly cycles of maintenance temozolomide.
Mary, Welch, Rose, Lai
openaire +2 more sources
Optimal management of newly diagnosed glioblastoma multiforme includes maximal surgical resection, followed by 60 Gy of external beam radiation plus concomitant daily temozolomide and at least six additional monthly cycles of maintenance temozolomide.
Mary, Welch, Rose, Lai
openaire +2 more sources
Current Treatment Options in Neurology, 2008
Patients with newly diagnosed glioblastoma multiforme should undergo a maximal tumor resection and then, whenever possible, should be entered into a clinical trial. The current standard of care consists of external beam irradiation, to a total of 60 Gy over 6 weeks, in combination with low-dose daily temozolomide, followed by at least six cycles of ...
openaire +2 more sources
Patients with newly diagnosed glioblastoma multiforme should undergo a maximal tumor resection and then, whenever possible, should be entered into a clinical trial. The current standard of care consists of external beam irradiation, to a total of 60 Gy over 6 weeks, in combination with low-dose daily temozolomide, followed by at least six cycles of ...
openaire +2 more sources